Structure Therapeutics Inc. (NASDAQ:GPCR) Receives $81.29 Consensus PT from Brokerages
Shares of Structure Therapeutics Inc. (NASDAQ:GPCR – Get Free Report) have been assigned a consensus rating of “Buy” from the eight research firms that are covering the company, MarketBeat reports. Eight equities research analysts have rated the stock with a buy recommendation. The average twelve-month price target among brokers that have updated their coverage on […]
Shares of Structure Therapeutics Inc. (NASDAQ:GPCR – Get Free Report) have been assigned a consensus rating of “Buy” from the eight research firms that are covering the company, MarketBeat reports. Eight equities research analysts have rated the stock with a buy recommendation. The average twelve-month price target among brokers that have updated their coverage on […]
